-
Is Big Pharma Poised To Take Over Cannabis? 3 Companies Already Manage 8 In 10 Drug Prescriptions In The US
Thursday, July 11, 2024 - 3:01pm | 860The U.S. Federal Trade Commission (FTC) recently highlighted the significant influence of pharmacy benefit managers (PBMs) on drug prices due to market consolidation. This trend raises critical questions about the future of the cannabis industry, especially if cannabis is federally legalized. The...
-
Does Anthem Want Cigna For $175/Share? Some Investors Are Buying Into The Rumor
Monday, June 15, 2015 - 12:46pm | 237According to Dow Jones, Anthem Inc (NYSE: ANTM) has initiated a takeover bid for CIGNA Corporation (NYSE: CI) at $175 per share. That's a premium of about 17 percent -- Cigna shares are up a little over 13 percent on the report. Cigna's insurance subsidiaries provide major medical,...
-
J.P. Morgan Maintains Rating, PT On CI
Thursday, June 16, 2011 - 8:54am | 200J.P. Morgan is maintaining its Overweight rating and its $55 price target on CIGNA Corp. (NYSE: CI) following meetings with the company's management. In its report, J.P. Morgan writes, “We recently held meetings with management. Overall, still an emphasis on the global focus/nature of the CI...
-
Morgan Stanley Comments On CIGNA Financial Model
Thursday, May 12, 2011 - 8:03am | 99According to Morgan Stanley, CIGNA (NYSE: CI) story is evolving away from traditional multi-line structure. Morgan Stanley said that even against a challenging backdrop over the last few years, CI has made progress in expanding its breadth, strengthening its capital position, and repositioning the...
-
Jefferies Reports Growth Spurt For Cigna
Friday, May 6, 2011 - 8:36am | 69According to Jefferies, Cigna (NASDAQ: CI) posted a great quarter with the three key segments beating earning estimates by 12-20%. 1Q11 EPS of $1.37 exceeded consensus by 26% and CI raised 2011 EPS guidance midpoint 7% to $4.83 (2% above consensus). Jefferies said that international top line...
-
Wedbush Raise PT On CI To $48
Tuesday, April 12, 2011 - 7:34am | 113Wedbush has announced that it is raising its price target on CIGNA Corp. (NYSE: CI) from $47 to $48. Wedbush maintains its Neutral rating on the stock. In the report, Wedbush writes, “Our Increased Estimates Reflect our Belief that Utilization and Flu Trends Remain Moderate. We also see potential...
-
Wedbush Raise PT On CI To $48
Tuesday, April 12, 2011 - 7:34am | 113Wedbush has announced that it is raising its price target on CIGNA Corp. (NYSE: CI) from $47 to $48. Wedbush maintains its Neutral rating on the stock. In the report, Wedbush writes, “Our Increased Estimates Reflect our Belief that Utilization and Flu Trends Remain Moderate. We also see potential...
-
Jefferies Raises EPS Estimate on Cigna Corp. (CI)
Monday, December 6, 2010 - 9:48am | 72Jefferies published its research report today on Cigna Corp. (NYSE: CI) in which it updates its EPS estimate on CI. In a note to clients, Jefferies writes, "With the lower cost debt issuance, and assuming substantial redemption of the 8.5% senior notes, we are increasing our '11 EPS forecast to $4....